Market Trends– category –
-
ORF Genetics Dramatically Cuts Cultivated Meat Production Costs by Producing Growth Factors Using Barley
Farmtario Canada Overview Barley is reported to play a crucial role in cultivated meat production without animal rearing. ORF Genetics developed an innovative technology to produce animal growth factors, essential for cultivated meat cel... -
Cytiva CEO Pierre-Alain Ruffieux Emphasizes Standardization and Automation for Scaling Cell and Gene Therapy Manufacturing Ahead of BIO 2026
BioPharm International USA Overview Ahead of BIO International Convention 2026, Cytiva CEO Pierre-Alain Ruffieux discussed scaling cell and gene therapy (CGT) manufacturing to expand global access. He emphasized standardization and autom... -
Cultivated Meat Institute Envisions Sustainable Future with >99% Media Cost Reduction and Significant Bioreactor Capacity Expansion
Alt Protein Planet USA Overview Dr. Elliot Swartz of the Cultivated Meat Institute reported that the cultivated meat industry has achieved over 99% reduction in media costs and significantly expanded bioreactor capacity over the past dec... -
Miltenyi Biotec’s Global T-Cell Manufacturing Platform Integrates Automated Closed Systems, Cuts Manual Labor by Over 70%, Achieves High Yields
Bioprocess Online Germany Overview Miltenyi Biotec proposes that global scaling of TCR-T cell manufacturing requires a fundamental process redesign, integrating six key production steps into a single automated, closed system. This integr... -
BioPharm International Emphasizes Standardization and Automation for Overcoming Complex Cell & Gene Therapy Manufacturing Challenges
BioPharm International USA Overview BioPharm International highlighted that standardization and automation are critical for navigating the complex landscape of cell and gene therapy (CGT) manufacturing. To improve global patient access t... -
Regulatory Complexity Poses Market Challenges for Cultivated Meat Products: US USDA Approval Amidst Inconsistent State Regulations
PetfoodIndustry USA Overview Regulatory complexity for cell-cultivated meat products poses significant challenges for manufacturers in consumer engagement. While the USDA approved cell-cultivated chicken sales in 2023 and established a r... -
BioProcess International Advocates for Building a Distributed Model for Future Autologous Cell Therapy Manufacturing
BioProcess International Netherlands Overview BioProcess International and IB Communications held a video roundtable proposing the construction of a distributed manufacturing model for the future of autologous cell therapy biomanufacturi... -
BioProcess International Reports on Mesenchymal Stem Cell (MSC) Large-Volume Manufacturing Challenges and Corning HYPERStack™ Contribution
BioProcess International USA Overview BioProcess International reported on the challenges and progress in large-volume manufacturing of mesenchymal stem cells (MSCs). The approval of two iPSC-derived therapies in Japan indicates growing ... -
New Market Pitch Evaluates Top Cell Therapy Startups Including Orca Bio, Cellares, and Kelonia: Differentiated by Clinical, Manufacturing, and Strategic Advancements
New Market Pitch USA Overview New Market Pitch selected ten leading cell therapy startups—Orca Bio, Kyverna, Cabaletta Bio, Cellares, Immatics, Iovance, Sana, Kelonia, Orna, and Dispatch Bio—evaluating their regulatory maturity, clinical... -
Cellbase Emphasizes Critical Role of Real-Time Monitoring Tools for Bioreactor Scale-Up
Cellbase Germany Overview Cellbase highlighted the imperative of integrating real-time monitoring tools for successful bioreactor scale-up. As bioreactor scale increases, single-point monitoring becomes inadequate, leading to mixing dela...
